Bristol-Myers Squibb (BMY) Tops Q4 EPS by 10c

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/10/2026

1. SPCX
2. HUM
3. ALHC
4. PEP
5. T
6. CVS
7. UNH
8. SBUX
9. AXP
10. ZETA

Go back to Bristol-Myers Squibb (BMY) Tops Q4 EPS by 10c

Bristol-Myers Squibb (BMY) Announces Early Stoppage of Opdivo Phase 3 in SCCHN

January 28, 2016 7:11 AM EST

Bristol-Myers Squibb Company (NYSE: BMY) announced that a randomized Phase 3 study evaluating Opdivo (nivolumab) versus investigators choice in patients with recurrent or metastatic platinum-refractory squamous cell carcinoma of the head and neck (SCCHN) was stopped early because an assessment conducted by the independent Data Monitoring Committee (DMC) concluded that the study... More